Thе appellant, Dr. William G. McBride, challenges the district court’s dismissal of his libel action against the American Association for the Advancement of Science, publisher of
Science
magazine;
Science
reporter Gina Bari Kolata; Merrell Dow Pharmaceuticals, Inc.
1
; and several of its officers. McBride claims that
Science
published a false and defamatory story about him and that the Merrell Dow defendants disseminatеd the story although knowing it was false. On cross-motions of the parties, the district court entered summary judgment against McBride.
McBride v. Mer-rell Dow and Pharmaceuticals, Inc.,
I.
The tortuous history of this case began when the October 31,1980 issue of Science featured an article by Kolata entitled “How Sаfe Is Bendectin?” The article discussed a Food and Drug Administration investigation that had commenced in response to widespread public concern over the pregnancy drug’s alleged links to birth defects. Doctor McBride, an Australian obstetrician and expert in teratology (the study of birth defects), testified before the FDA. McBride had рreviously served as an expert witness for plaintiffs who challenged Bendectin’s safety in a lawsuit filed against Merrell Dow in Orlando, Florida. Kolata wrote:
These expert witnesses [at the FDA hearing] included William McBride of the Women’s Hospital in Sydney, Australia, who was paid $5,000 a day to testify in Orlando. In contrast, [Merrell Dow] pays witnesses $250 to $500 a day, and the most it has ever paid is $1,000 a day.
*1210
McBride brought suit, claiming that this statement and several others
2
were libelous. The district court initially dismissed the case for failure to state a claim, holding that none of the statements was defamatory as a matter of law.
McBride v. Merrell Dow and Pharmaceuticals,
On remand, the district court restricted the scope of discovery to facts bearing on Doctor McBride’s status as a public figure
vel non
and on McBride's expert witness fee. The court rejected McBride’s effort to obtain discovery relating to the fees that Merrell Dow had paid
its
expert witnesses. The district court then granted the defendants’ motion for summary judgment. Although the defendants based their motion on the ground that the fee statement was “substantially true,” the district court awarded judgment on the bаsis of the Mer-rell Dow defendants’ lack of knowledge of its alleged falsity and the
Science
defendants' lack of actual malice in making the statement (McBride being deemed a public figure).
See McBride,
II.
A.
We begin by affirming the district court’s entry of summary judgment for thе Merrell Dow defendants. McBride failed to advance any reasons in his opening brief why that judgment should be reversed; he made such an argument only in his reply brief, after the appellees pointed out McBride’s omission and suggested that his claim against the Merrell Dow defendants had been waived. This court ordinarily will refuse to disturb judgments on the basis оf claims not adequately briefed on appeal.
See Railway Labor Executives’ Ass’n v. U.S.R.R. Retirement Bd.,
The appellant’s failurе to raise the issue in timely fashion is particularly inexcusable in this case. What McBride omitted from his opening brief was not merely an argument or legal theory supporting a claim, but any mention of a claim against Merrell Dow. Though he disputed the district court’s disposition of his libel claim against the Science defendants, McBride failed to address the separate legal issue implicated by his claim against the Merrell Dow defendants. This is not a situation in which an appellant incorporates by reference or otherwise “implicitly” raises a generic legal claim against all parties. It would, consequently, be patently inequitable to force Merrell Dow to defend an appeal by guessing the arguments that the appellant might make in his reply brief. We affirm the dismissal of the Merrell Dow defendants from this case.
B.
We turn to McBride’s claims against the
Science
defendants. The district court held that McBride is a public figure for purposes of the controversy covered by the allegedly libelous story, and thus would have to satisfy the “actual malice” standard of
New York Times v. Sullivan,
Indeed, McBride’s role in the Bendectin controversy is a paradigm of the limited-purpose public figure concept. The alleged link betweеn Bendectin and birth defects had begotten a widespread and heated public controversy over the drug’s safety.
See Waldbaum,
As a public figure, McBride must prove that the defendants acted with actual malice to recover. Had the defendants properly advanced and supported a motion for summary judgment on that issue, McBride would face dismissal unless he could adduce sufficient evidence from which a reasonable jury could find by clear and convincing evidence that the defendants acted with actual malice.
See Ander
*1212
son v. Liberty Lobby, Inc.,
— U.S.-,
The district court seems to have believed that disposition of the actual malice issue did not require factual development:
i.e.,
that even accepting as true the faсts alleged in McBride’s complaint, the defendants were entitled to judgment as a matter of law. The court maintained that the uncertainty of comparing fees and the ambiguity of the statement indicated that the defendants could not have acted with actual malice.
See
While apparently conceding the foregoing, the defendants nonetheless argue that the district court’s judgment may be upheld on alternative grounds.
See, e.g., Hoffa v. Fitzsimmons,
Because McBride bears the ultimate burden of persuading the factfinder that the statement was false, the defendants’ burden of production in support of their summary judgment motion is not great. The defеndants need merely “ ‘show[ ]’— that is, point[ ] out to the District Court— that there is an absence of evidence to support the [plaintiff’s] case.”
Catrett,
In remanding the case to the district court, we wish to emphasize that we do not declare that summary disposition of this case is inconceivable, only that it was improperly ordered here. After affording the parties adequate opportunity for discovery, see supra note 3, the district court may entertain properly supported motions for summary judgment. And, as this court previously suggested, it would be entirely appropriate for the district court to limit discovery initially to the potentially disposi-tive issue of falsity. In this way, the potentially more burdensome discovery into the defendants’ editorial process entailed by exploration of the actual malice issue would become necessary only if the plaintiff demonstrated a triable dispute about the falsity of the fee comparison. While we repeat the suggestion of our prior panel opinion, however, we recognize that the order and timing of discovery are matters that ultimately lie within the district court’s discretion.
For the reasons stated herein, the judgment of the district court is affirmed in part and reversed in part, and the case is remanded to the district court for appropriate proceedings.
It is so ordered.
Notes
. Throughout this litigation, the company has been erroneously referred to as "Merrell Dow and Pharmaceuticals, Inc.".
. One statement implied that McBride was one “of [attorney Melvin] Belli’s witnesses”; the second referred to remarks by an FDA panel mem-her suggesting that McBride’s testimony was irrelevant or long-winded.
. Beсause we believe that the prerequisites for the entry of summary judgment on the actual malice issue were not satisfied,
i.e.,
a properly supported motion by the defendants or sufficient notice by the district court, we do not reach the question of whether summary judgment should have been denied on the ground of McBride’s lack of opportunity to obtain discovery.
See Catrett,
. There appears to be some question over whether this burden is discharged by a bare allegation that the plaintiff has insufficient evidence to get to the jury, or whether something more, such as citation to relevant depositions or answers to interrogatories, is required.
See Ca-trett,
. Despite being barred from deposing Merrell Dow’s expert witnesses, McBride actually sought partial summary judgment relating to the falsity of the fee comparison. McBride introduced а deposition of one of Merrell Dow’s expert witnesses obtained in the Orlando litigation itself. Dr. Olli Heinonen there testified that he "guessed” that he was paid $800 to $1,000 per day for his service to Merrell Dow. McBride argues that this evidence, together with his own depositions, shows that he and Heinonen were each paid approximately $1,000 per day for each day away from his medical practice, and thus that the fee comparison is false as a matter of law. We disagree. To begin with, Heino-nen’s testimony is sketchy and does not clearly disclose the method by which he was estimating his fee. In any event, as the district court recognized, the "per day” fee comparison drawn by Science could be read as comparing expert witness compensation for days spent away from medical practices, for days spent in court, or on some other basis. If the gist of the fee comparison were "false” under one method of calculating fees but "true” under another method, the question as to which comparison the statement in fact conveyed would be for the jury, not the district court.
